2024-11-29 06:51:56
iNtRON Completes GLP-TOX Studies of BAL200
Corporate/ 2023-07-24
iNtRON Completes GLP-TOX Studies of BAL2...

A novel drug candidate for anthrax received orphan drug designation (ODD) by the US FDA. BOSTON and SEOUL,Korea,June 7,2022-- iNtRON Biotech...

ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3%
Corporate/ 2023-07-24
ASCO 2022 | The First Dataset of Olverem...

SUZHOU,China,and ROCKVILLE,Md.,June 7,2022-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel thera...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release